A novel point mutation in an acceptor splice site of intron 32 (IVS32 A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb

被引:25
作者
Okubo, M
Horinishi, A
Nakamura, N
Aoyama, Y
Hashimoto, M
Endo, Y
Murase, T
机构
[1] Toranomon Gen Hosp, Dept Endocrinol & Metab, Minato Ku, Tokyo 105, Japan
[2] Okinaka Mem Inst Med Res, Minato Ku, Tokyo 105, Japan
[3] Univ Tsukuba, Dept Pediat, Tsukuba, Ibaraki 305, Japan
[4] Toranomon Gen Hosp, Dept Digest Surg, Minato Ku, Tokyo 105, Japan
[5] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo 105, Japan
关键词
D O I
10.1007/s004390050646
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic deficiency of the glycogen-debranching enzyme (debrancher) causes glycogen storage disease type III (GSD III), which is divided into two subtypes: IIIa and IIIb. In GSD IIIb, glycogen accumulates only in the liver, whereas both liver and muscles are involved in CSD IIIa. The molecular basis for the differences between the two subtypes has not been fully elucidated. Recently, mutations in exon 3 of the debrancher gene were reported to be specifically associated with GSD IIIb, However, we describe a homozygous GSD IIIb patient without mutations in exon 3. Analysis of the patient's debrancher cDNA revealed an Il-bp insertion in the normal sequence. An A to G transition at position -12 upstream of the 3' splice site of intron 32 (IVS 32 A(-12)-->G) was identified in the patient's debrancher gene. No mutations were found iii exon 3. Mutational analysis of the family showed the patient to be homozygous for this novel mutation as well as three polymorphic markers. Furthermore, the mother was heterozygous and the parents were first cousins. The acceptor splice site mutation created a new 3' splice site and resulted in insertion of an Il-bp intron sequence between exon 32 and exon 33 in the patient's debrancher mRNA. The predicted mutant enzyme was truncated by 112 amino acids as a result of premature termination. These findings suggested that a novel IVS 32 A(-12)-->G mutation caused GSD IIIb in this patient.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 17 条
[1]   Human glycogen debranching enzyme gene (AGL): Complete structural organization and characterization of the 5' flanking region [J].
Bao, Y ;
Dawson, TL ;
Chen, YT .
GENOMICS, 1996, 38 (02) :155-165
[2]  
Chen Y.T., 1995, METABOLIC MOL BASES, P935
[3]  
HASHIMOTO M, J GASTROENTEROL HEPA
[4]   ABERRANT SPLICING AND MISSENSE MUTATIONS CAUSE STEROID 21-HYDROXYLASE [P-450(C21)] DEFICIENCY IN HUMANS - POSSIBLE GENE CONVERSION PRODUCTS [J].
HIGASHI, Y ;
TANAE, A ;
INOUE, H ;
HIROMASA, T ;
FUJIIKURIYAMA, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) :7486-7490
[5]  
HUIE ML, 1994, HUM MOL GENET, V3, P2231
[6]  
KAJIHARA S, 1995, AM J HUM GENET, V57, P549
[7]  
KRAWCZAK M, 1992, HUM GENET, V90, P41
[8]   A G(+1) to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency - A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient [J].
Okubo, M ;
Hasegawa, Y ;
Aoyama, Y ;
Murase, T .
ATHEROSCLEROSIS, 1997, 130 (1-2) :153-160
[9]   A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III [J].
Okubo, M ;
Aoyama, Y ;
Murase, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) :493-499
[10]  
Okubo M, 1997, CLIN GENET, V51, P179